Connect to other sites within the UBM Medica Network
Anticoagulant Use Among Afib Patients Wanes Over Time
Study results presented at the 2015 AHA meeting reinforce, once again, the critical role of persistent patient education on treatment adherence.
Risk of Atrial Fibrillation Increased in HFpEF
Data from a recent study suggest that paroxysmal AF may be underdiagnosed in patients with heart failure and preserved ejection fraction.
At Long Last, an Antidote for a NOAC!
The anticoagulant reversal agent idarucizumab was approved as the antidote to dabigatran via the FDA's accelerated approval program.
Atrial Fibrillation May Increase Risk of Dementia
Younger patients with AF of longer duration were found at higher risk for dementia, a recent study found.
Ablation Therapy for AF: Who, What is it Good For?
Guidelines recommend AF catheter ablation to help avoid use of oral anticoagulation. True or False? Answer this and 2 other queries on ablation.
Persistent AF Improved via LAA Isolation
Results of the BELIEF study presented at ESC 2015 suggest the adjunctive ablation procedure may enhance long-term rhythm control.
ESC '15: Real World Patients, Real World Numbers from GARFIELD-AF
The first results from the largest ongoing international registry of newly diagnosed AF patients were long awaited, and worth the wait.
By clicking Accept, you agree to become a member of the UBM Medica Community.